FDA panel votes to loosen restrictions on controversial peptides0

• Gear / Gear News and Events, General, News, Newsletters, Security / Security News
• July 24, 2026

A US Food and Drug Administration (FDA) advisory panel voted to loosen restrictions on controversial peptides that have become popular online but have not been well researched for use in humans. The panel voted narrowly to allow specialty pharmacies to produce drugs such as BPC-157, TB-500 and KPV, a major regulatory hurdle to making them